Approval · Notice of Compliance 2781 · 1998
DOVONEX: Notice of Compliance 2781
Issued May 27, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2781
- Date
- May 27, 1998
- Company
- Leo Laboratories Canada Ltd.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: for the topical treatment of mild to moderate psoriasis in children aged 2 years and older
- Therapeutic class
- Topical non-steroidal antipsoriatic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOVONEX | Not yet assigned | — |
Medicinal ingredients
- CALCIPOTRIOL 50 MCG per G